Central Pharmaceuticals Working Capital Management

Overview
This repository contains a detailed analysis of the working capital management of Central Pharmaceuticals, one of the top ten pharmaceutical manufacturers in Bangladesh. The analysis evaluates various financial aspects using ratio analysis and includes a SWOT analysis for deeper insights into the company's operations.

Content
The repository contains:
1. Financial Analysis:
Net t Working Capital (2012-2022)
Current Ratio (2012-2022)
Cash Conversion Cycle (2012-2022)
Inventory Turnover Ratio (2012-2022)
Average Collection Period (2012-2022)
Quick Ratio (2012-2022)
Accounts Receivable Turnover (2012-2022)

SWOT Analysis:
Strengths:
Strong management team
Modern technology adoption
Innovative product lines

Weaknesses:
Delays in supplier payments
Weak marketing strategies

Opportunities:
Expansion into developing markets
Scope for improving customer satisfaction

Threats:
Competitive market
Government trade barriers

 Conclusions & Recommendations:
Strong current and quick ratios
Consistent inventory turnover ratios

Recommendations for market segmentation and strategic buyer relationship development

How to Use
Clone the repository:
git clone https://github.com/yourusername/central-pharmaceuticals-working-capital

View the presentation: The analysis is structured around a PowerPoint presentation, which can be found in the presentation/ directory.

Contribution

If you'd like to contribute or suggest improvements, feel free to open a pull request or an issue.
